The woman once celebrated as the youngest self-made female billionaire in America now answers to a federal inmate register number at a minimum-security prison camp outside Houston. Her fortune, $4.5 billion on paper at the Theranos peak, is gone. Her restitution bill is $452 million. Her projected release date: 2032.
This page tracks where Elizabeth Holmes is now, and we update it as the story moves. Unlike the news cycle, her sentence keeps running.
Key Takeaways
- Elizabeth Holmes is in FPC Bryan, a minimum-security federal prison camp in Bryan, Texas, where she has been held since May 2023.
- Her projected release is 2032, several years ahead of her full 11-year-3-month sentence, thanks to good-conduct credits.
- She owes about $452 million in restitution, jointly with Sunny Balwani, an amount widely considered uncollectable given her stated lack of assets.
- She still disputes the fraud narrative, describing Theranos as a failure rather than a fraud in interviews given from prison; her appeals were rejected.
- Her partner Billy Evans is building Haemanthus, a new blood-testing startup that reporting says she has advised from prison.
The Short Version
| Question | Answer (as of July 2026) |
|---|---|
| Where is she? | FPC Bryan, a minimum-security federal prison camp in Bryan, Texas |
| Why? | Convicted January 2022 on four counts of defrauding Theranos investors |
| Sentence | 11 years 3 months, plus 3 years supervised release |
| Projected release | 2032, earlier than the full term thanks to good-conduct credits |
| Restitution | ~$452 million, shared with Sunny Balwani |
| Family | Two young children with partner Billy Evans, who visits with them regularly |
What Is Life Like for Holmes in Prison?
Holmes lives in dormitory housing at a minimum-security work camp, holds a prison job, and by multiple accounts spends her time on inmate-support programs and on relitigating her own story in interviews. FPC Bryan is about as far from Silicon Valley as the federal system offers: dormitory housing, prison jobs that pay cents per hour, visiting hours on weekends. Reporting from her time inside has described Holmes working in reentry support and victim-advocacy programs, helping other inmates prepare for release and, in long interviews given from the camp, quietly relitigating her own story.
Because that’s the constant: Holmes has never really conceded the premise. In her telling, Theranos was a failure, a startup that ran out of time, rather than a fraud. Juries, judges and appeals courts have disagreed, point by point. Her conviction was upheld, and the Supreme Court declined to hear the case.
How Did Holmes Get Caught in the First Place?
The fraud unraveled through journalism, not regulation: John Carreyrou’s October 2015 Wall Street Journal investigation revealed that Theranos ran most of its tests on modified commercial machines, not its own devices. Regulators followed: a federal lab inspection found deficiencies serious enough to threaten patient safety, Walgreens terminated the partnership, and by 2018 the SEC had charged Holmes, a grand jury had indicted her, and the company had dissolved.
The trial took three more years to arrive and four months to run. In January 2022, a jury convicted her on four counts of defrauding investors while acquitting her on the counts tied to patients, a split verdict that still defines how the story gets argued about. Balwani, tried separately, was convicted on all twelve counts he faced and is serving nearly thirteen years.
Does Holmes Have to Pay the Money Back?
Legally yes, practically no. The $452 million restitution order is, in practical terms, symbolic. Holmes testified to having negligible assets; her legal bills alone were reported to have consumed millions provided by others. Investors who lost fortunes (the Waltons, Rupert Murdoch, Betsy DeVos’s family) wrote their checks off long ago. Murdoch famously sold his ~$125 million stake back to Theranos for one dollar, taking the tax loss.
The deeper accounting was never financial anyway. Theranos ran real blood tests on real patients, tens of thousands of them, and voided or corrected nearly a million results. The people who made medical decisions based on those numbers are the constituency the restitution order can’t reach.
The Sequel Nobody Expected
Here’s where the story bends toward the unbelievable: while Holmes sits in Bryan, her partner Billy Evans has been raising money for a startup called Haemanthus: a diagnostics company working on, yes, blood testing. Reporting in 2025 indicated Holmes has informally advised the venture from prison.
We covered that story in full in our investigation of Haemanthus and the “Theranos trick”, including the uncomfortable question it raises: if the same pitch, adjacent to the same people, can raise millions less than a decade after the original fraud, what exactly did the market learn? It’s a pattern regular readers of our scandals coverage will recognize: memory in venture capital is short, and charisma amortizes fast.
Where Is Sunny Balwani Now?
Ramesh “Sunny” Balwani (Theranos’s president, Holmes’s former partner, and the other half of the fraud) is serving a longer sentence than she is. Tried separately in 2022, he was convicted on all twelve counts he faced, including the patient-fraud counts on which Holmes was acquitted, and sentenced to nearly thirteen years. He has reportedly been held at a federal facility in California, with a projected release in the mid-2030s.
The asymmetry between their verdicts still fuels argument. Holmes’s defense painted Balwani as the controlling force behind the numbers; his trial, running months after hers, had the misfortune of following a public that had already made up its mind. Neither appeal succeeded. Between them, the two people who ran Theranos will have spent roughly a quarter-century in federal custody for a company that never sold a working product.
The Critical Choice
Every retrospective asks when Theranos crossed from ambition into crime. The cleanest answer from the trial record: the moment Holmes chose to put unproven technology in front of real patients, using modified third-party machines while telling the world (and Walgreens) her devices did the work. Everything before that was Silicon Valley theater; plenty of startups fake it politely. Patients turned the fake into a body count of trust. That made the eventual reckoning, chronicled from the first Wall Street Journal story to the verdict, a matter of when, not if.
Where Things Stand Now
Holmes remains at FPC Bryan with a projected 2032 release, still planning, by her own account, a return to healthcare. Balwani, convicted on more counts, is serving nearly thirteen years. Theranos itself dissolved in 2018; its patents scattered, its Edison machines now museum pieces of a very specific era of belief. This page will be updated as anything material changes: appeals, transfers, early release, or the next chapter of Haemanthus.
